Skip to main content
. 2021 Aug 21;304(5):1259–1269. doi: 10.1007/s00404-021-06192-7

Table 3.

Surgical parameters in correlation with intraoperative complications

Surgical parameters in correlation with intraoperative complications (n = 3351)
Intraoperative complications p-value
Yes No
Total (%)
Indication  ≤ 0.01
 Uterus myomatosus 44 (23.4%) 779 (24.6%)
 Benign adnexal finding 35 (18.6%) 865 (27.3%)
 Malignant adnexal finding 31 (16.5%) 84 (2.7%)
 Endometrial cancer 23 (12.2%) 128 (4.0%)
 Cervical cancer 17 (9.0%) 114 (3.6%)
 Endometriosis 16 (8.5%) 521 (16.5%)
 Others 16 (8.5%) 478 (15.1%)
 Urogynaecological indication 6 (3.2%) 156 (4.9%)
 CIN 0 (0.0%) 38 (1.2%)
Malignancy  ≤ 0.01
 Yes 76 (40.4%) 345 (10.9%)
 No 112 (59.6%) 2818 (89.1%)
Barakat-classification  ≤ 0.01
 Grade II 87 (46.3%) 2397 (75.8%)
 Grade IV 69 (36.7%) 276 (8.7%)
 Grade III 32 (17.0%) 429 (13.6%)
 Grade I 0 (0.0%) 61 (1.9%)
ASA-classification  ≤ 0.01
 Grade II 109 (58.0%) 1971 (62.3%)
 Grade III 51 (27.1%) 335 (10.6%)
 Grade I 27 (14.4%) 853 (27.0%)
 Grade IV 1 (0.5%) 4 (0.1%)
Adhesiolysis 0.39
 Yes 115 (61.2%) 1835 (58.0%)
 No 73 (38.8%) 1328 (42.0%)
Body mass index  ≤ 0.01
 Normalweight 79 (42.0%) 1470 (46.5%)
 Overweight 38 (20.2%) 878 (27.8%)
 Obesity I 32 (17.0%) 414 (13.1%)
 Obesity III 19 (10.1%) 112 (3.5%)
 Obesity II 12 (6.4%) 186 (5.9%)
 Underweight 8 (4.3%) 103 (3.3%)
Median (minimum–maximum)
Yes No
Age (years) 50 (21–87) 42 (9–95)  ≤ 0.01
Body mass index (kg/m2) 26.1 (16.3–59.5) 25 (15.6–62.5)  ≤ 0.01
Operative time (min) 180 (24–492) 79 (2–415)  ≤ 0.01
Carbon dioxide use (l) 255 (7.7–1373) 153 (7.4–2060) 0.02
Hemoglobin drop (g/dl) 1.5 (− 4.2–5.7) 1,0 (− 2.2–8.5)  ≤ 0.01
Length of hospital stay (days) 7 (0–75) 3 (0–72)  ≤ 0.01

CIN cervical intraepithelial neoplasia, ASA Classification American society of anaesthesiologists classification (n = 3351)